South Wales, Feb. 27 -- United Kingdom Intellectual Property Office (UKIPO) has registered trademark "DREN BIO" on Feb. 11. The details about the trademark application no. UK00004339401 published in the journal no. 2026/009 (Feb. 27).
With CMS Cameron McKenna Nabarro Olswang LLP as representative, Dren Bio Management, Inc. filed the trademark application for the below mentioned good(s)/service(s).
Class 5 : Pharmaceuticals; medical preparations; Pharmaceutical preparations for use in cancer, neurological disorders, allergies, infectious diseases, immunologic diseases, orphan diseases, rare diseases, and autoimmune disease treatment; pharmaceutical preparations for use in the fields of oncology, neurology, allergy, infectiology, immunology, autoimmunity, orphan diseases, rare diseases, and immunity; pharmaceutical preparations for tumor treatment; pharmaceutical preparations for suppressing tumors; pharmaceutical products for the prevention and treatment of cancer, neurological disorders, allergies, infectious diseases, immunologic diseases, orphan diseases, rare diseases, and autoimmune diseases.
Class 42 : Scientific research and development; pharmaceutical research and development; research and development in the field of biotechnology; research and development of pharmaceuticals in the fields of oncology, neurology, allergy, infectiology, immunology, autoimmunity, orphan diseases, rare diseases, and immunity; research and development of pharmaceuticals for treating tumors; research and development services in the field of medical and pharmaceutical preparations; research and development of pharmaceuticals for the treatment of cancer, neurological disorders, allergies, infectious diseases, immunologic diseases, orphan diseases, rare diseases, and autoimmune diseases; pharmaceutical research in the fields of oncology, tumor suppression, neurology, allergy, infectiology, immunology, autoimmunity, orphan diseases, rare diseases, and immunity; information, consultancy and advisory services in relation to all of the above.
The original document can be viewed at: http://www.ipo.gov.uk/cgi-bin/redirect.cgi?type=tmj&link=6¶m1=UK00004339401
Disclaimer: Curated by HT Syndication.
